Tirzepatide 10mg

• Dual Action: It acts as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist.
• Insulin Release: It tells the pancreas to release more insulin when blood sugar is high.
• Appetite Control: It slows stomach digestion and targets areas in the brain that control hunger to increase a feeling of fullness. 

Administration and Side Effects

• How It Is Taken: Given as a subcutaneous injection (under the skin) once a week.
• Common Side Effects: Nausea, vomiting, diarrhea, constipation, and stomach pain